Leveraging Your Pharmaceutical Product Portfolio: Driving M&A And Target Identification Through Research-Driven Strategies - Informa Pharma Intelligence
May 18 2022
11:00 AM - 12:00 PM
Barbara Binzak Blumenfeld and Matthew Fedowitz presented a webinar in partnership with Informa Pharma Intelligence entitled "Leveraging Your Pharmaceutical Product Portfolio: Driving M&A And Target Identification Through Research-Driven Strategies."
Whether your company has a brand name drug that is facing impending expiration of patent or market exclusivity, you represent a generic drug company looking to introduce or acquire a product, or you are an investor looking to drive the value of a deal based on a company’s drug product offerings, you need to be able to evaluate a pharmaceutical product portfolio against the broader drug industry landscape, anticipate potential roadblocks, and strategically determine growth areas and next steps.
Key takeaways included:
Gaining insight into the value of a comprehensive IP/FDA regulatory pharmaceutical product analysis for driving strategic portfolio growth.
Understanding how and why IP and FDA regulatory factors can be a driver of the value of a pharmaceutical product portfolio or deal.
Learning how to assess, identify, and capitalize on gaps in your current product portfolio.
If you missed the webinar, you can view the recording here or view a summary of the presentation here.